Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Anemias, Adult, AML, aplastic anemia, Diseases, iPSCs, Diamond Blackfan Anemia, Bone Marrow Failure, Genetic Disorders, Fanconi Anemia, MDS, red blood cells, Biological Processes, DNA damage, MPN, PNH, Cell Lineage, erythropoiesis, Study Population, genomics, Clinically relevant, Myeloid Malignancies, hematopoiesis, immune mechanism
Type: Oral
Hematology Disease Topics & Pathways:
Anemias, Adult, AML, aplastic anemia, Diseases, iPSCs, Diamond Blackfan Anemia, Bone Marrow Failure, Genetic Disorders, Fanconi Anemia, MDS, red blood cells, Biological Processes, DNA damage, MPN, PNH, Cell Lineage, erythropoiesis, Study Population, genomics, Clinically relevant, Myeloid Malignancies, hematopoiesis, immune mechanism
Saturday, December 5, 2020: 2:00 PM-3:30 PM
Moderators:
Daria V. Babushok, MD, PhD,
and
Austin G Kulasekararaj, MD, MBBS, MRCP, FRCPath, King’s College Hospital NHS Foundation Trust, King’s College, London, UK, and NIHR Wellcome King’s Clinical Research Facility
Disclosures:
Kulasekararaj: Alnylam: Honoraria, Membership on an entity's Board of Directors or advisory committees; Amgen: Membership on an entity's Board of Directors or advisory committees; Regeneron: Honoraria, Membership on an entity's Board of Directors or advisory committees; BioCryst: Honoraria, Membership on an entity's Board of Directors or advisory committees; Achilleon: Honoraria, Membership on an entity's Board of Directors or advisory committees; Apellis: Membership on an entity's Board of Directors or advisory committees; Ra Pharma: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Alexion Pharmaceuticals Inc.: Honoraria, Membership on an entity's Board of Directors or advisory committees; Celgene/BMS: Honoraria, Membership on an entity's Board of Directors or advisory committees; Roche: Honoraria, Membership on an entity's Board of Directors or advisory committees; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH